Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10308608 | 0.82 | ALDH1A1 (0.42) | NAALAD2ALDH1A1 | |
| SCHEMBL12537111 | 0.82 | ALDH1A1 (0.42) | NAALAD2ALDH1A1 | |
| SCHEMBL22301081 | 0.76 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL19477961 | 0.76 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL22929150 | 0.75 | NAALAD2 (0.31) | NAALAD2 | |
| SCHEMBL23446779 | 0.75 | L3MBTL1 (0.32) | — | |
| SCHEMBL12766314 | 0.74 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL29328853 | 0.74 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL26922716 | 0.73 | NOD1 (0.36) | ALDH1A1 | |
| SCHEMBL24234656 | 0.72 | KMT2A (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10905766-B2 | Therapeutic compositions and methods for treatment of muscle wasting diseases | OREGON STATE UNIVERSITY (US) | 2021-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10905766-B2 | Therapeutic compositions and methods for treatment of muscle wasting diseases | TNNC1, PYGM, MYLK2 | NAALAD2 3912/4885CYP1A2 4880/4885ALDH1A1 4503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.